BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

767 related articles for article (PubMed ID: 18599548)

  • 1. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.
    Bhavnani BR; Tam SP; Lu X
    Endocrinology; 2008 Oct; 149(10):4857-70. PubMed ID: 18599548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
    Bhavnani BR
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):473-82. PubMed ID: 12943738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analyses of vitellogenin, choriogenin and estrogen receptor subtypes in the livers of male medaka (Oryzias latipes) exposed to equine estrogens.
    Ishibashi H; Uchida M; Koyanagi A; Kagami Y; Kusano T; Nakao A; Yamamoto R; Ichikawa N; Tominaga N; Ishibashi Y; Arizono K
    J Appl Toxicol; 2016 Nov; 36(11):1392-400. PubMed ID: 26863931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of a B-ring unsaturated estrogen: implications for conjugated equine estrogen components of premarin.
    Hsieh RW; Rajan SS; Sharma SK; Greene GL
    Steroids; 2008 Jan; 73(1):59-68. PubMed ID: 17949766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism.
    Bhavnani BR
    Proc Soc Exp Biol Med; 1998 Jan; 217(1):6-16. PubMed ID: 9421201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus.
    Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M
    Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine estrogens differentially prevent neuronal cell death induced by glutamate.
    Bhavnani BR; Berco M; Binkley J
    J Soc Gynecol Investig; 2003 Jul; 10(5):302-8. PubMed ID: 12853093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
    Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
    Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine-disrupting potentials of equine estrogens equilin, equilenin, and their metabolites, in the medaka Oryzias latipes: in silico and DNA microarray studies.
    Uchida M; Ishibashi H; Yamamoto R; Koyanagi A; Kusano T; Tominaga N; Ishibashi Y; Arizono K
    J Appl Toxicol; 2015 Sep; 35(9):1040-8. PubMed ID: 25611945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding.
    Zhu BT; Han GZ; Shim JY; Wen Y; Jiang XR
    Endocrinology; 2006 Sep; 147(9):4132-50. PubMed ID: 16728493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
    Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
    Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel ligands balance estrogen receptor β and α agonism for safe and effective suppression of the vasomotor response in the ovariectomized female rat model of menopause.
    McGregor C; Sau A; Ruddy SC; Leung D; Webb M; Durst T; Wright JS; Lagace D; Pratt MA
    Endocrinology; 2014 Jul; 155(7):2480-91. PubMed ID: 24823389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
    Zhou S; Turgeman G; Harris SE; Leitman DC; Komm BS; Bodine PV; Gazit D
    Mol Endocrinol; 2003 Jan; 17(1):56-66. PubMed ID: 12511606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line.
    Gottfried-Blackmore A; Croft G; McEwen BS; Bulloch K
    Brain Res; 2007 Dec; 1186():41-7. PubMed ID: 18021758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors.
    Stossi F; Barnett DH; Frasor J; Komm B; Lyttle CR; Katzenellenbogen BS
    Endocrinology; 2004 Jul; 145(7):3473-86. PubMed ID: 15033914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
    Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
    Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
    J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
    Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
    Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.